InterMed Discovery (IMD), a world class natural product lead-discovery company located in the BioMedizinZentrumDortmund, announced the acquisition of unique microbal Omega-3 fatty acid production stains and related know-how from the University of Saarland. A shining example for good practice technology transfer.

Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates present in serum of patients with prostate cancer using the proprietary UNIArray® technology platform. In Europe, prostate cancer is the second most frequent lethal malignancy in men. Yearly about 40,000 men die of prostate cancer in the European Union.